Free Trial
NYSE:INFU

InfuSystem (INFU) Stock Price, News & Analysis

$6.44
-0.07 (-1.08%)
(As of 03:09 PM ET)
Today's Range
$6.43
$6.61
50-Day Range
N/A
52-Week Range
$5.74
$10.99
Volume
65,461 shs
Average Volume
50,172 shs
Market Capitalization
$137.14 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

About InfuSystem

InfuSystem Holdings, Inc., through its subsidiaries, provides infusion pumps, and related products and services in the United States and Canada. The company operates in two segments, Patient Services and Device Solutions. It supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states. The company also sells, rents, and leases new and pre-owned pole-mounted and ambulatory infusion pumps, and other durable medical equipment; sells treatment-related consumables; and provides biomedical recertification, maintenance, and repair services for oncology practices, as well as other healthcare site settings comprising hospitals, home care and home infusion providers, skilled nursing and acute care facilities, pain centers, and others. In addition, it offers local and field-based customer support, as well as operates pump service and repair centers. The company was incorporated in 2005 and is headquartered in Rochester Hills, Michigan.

INFU Stock Price History

INFU Stock News Headlines

InfuSystem Set For Strong Second Half
War on Elon Escalates…
Elon Musk, the guy slated to become the world’s first trillionaire by 2027, has publicly called for the adoption of this technology for decades. By doing so he has put himself in the crosshairs of an ideological war with the global elites. And yet, while this new technology threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth.
War on Elon Escalates…
Elon Musk, the guy slated to become the world’s first trillionaire by 2027, has publicly called for the adoption of this technology for decades. By doing so he has put himself in the crosshairs of an ideological war with the global elites. And yet, while this new technology threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth.
LDDD Longduoduo Company Limited
INFU Feb 2025 5.000 call (INFU250221C00005000)
Range Impact Reports 1Q 2024 Financial Results
Q1 2024 Sanara Medtech Inc Earnings Call
See More Headlines
Receive INFU Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for InfuSystem and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
8/08/2024
Today
9/16/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Surgical & medical instruments
Sub-Industry
N/A
Employees
499
Year Founded
N/A

Profitability

Net Income
$870,000.00
Pretax Margin
1.44%

Debt

Sales & Book Value

Annual Sales
$129.37 million
Cash Flow
$0.64 per share
Book Value
$2.47 per share

Miscellaneous

Free Float
19,123,000
Market Cap
$137.14 million
Optionable
Optionable
Beta
1.46
Beginner's Guide to Pot Stock Investing Cover

Click the link below and we'll send you MarketBeat's guide to pot stock investing and which pot companies show the most promise.

Get This Free Report

Key Executives

  • Mr. Richard A. DiIorio (Age 49)
    CEO & Director
    Comp: $1.14M
  • Ms. Carrie A. Lachance B.S.N. (Age 47)
    M.B.A., R.N., President, COO & Director
    Comp: $831.31k
  • Mr. Barry G. Steele (Age 53)
    Executive VP & CFO
    Comp: $725.43k
  • Mr. Addam Chupa (Age 45)
    Executive VP & Chief Information Officer
  • Mr. Jerod Funke (Age 49)
    Executive VP & Chief HR Officer
  • Jeanie Latz
    Corporate Secretary

INFU Stock Analysis - Frequently Asked Questions

How have INFU shares performed this year?

InfuSystem's stock was trading at $7.14 on January 1st, 2024. Since then, INFU shares have decreased by 9.8% and is now trading at $6.44.
View the best growth stocks for 2024 here
.

How were InfuSystem's earnings last quarter?

InfuSystem Holdings, Inc. (NYSE:INFU) posted its quarterly earnings results on Thursday, August, 8th. The company reported $0.03 EPS for the quarter, missing the consensus estimate of $0.04 by $0.01. The business had revenue of $33.70 million for the quarter. InfuSystem had a trailing twelve-month return on equity of 0.70% and a net margin of 0.28%.

Who are InfuSystem's major shareholders?

InfuSystem's top institutional investors include First Eagle Investment Management LLC (3.13%), Meros Investment Management LP (2.89%), Dimensional Fund Advisors LP (2.02%) and Cove Street Capital LLC (1.08%). Insiders that own company stock include Richard Dilorio, Christopher R Sansone, Carrie Lachance, Barry G Steele, Paul Andrew Gendron, R Rimmy Malhotra, Thomas Mark Ruiz, Addam Chupa, Ralph F Boyd Jr, Kevin Whitman, Gregg Owen Lehman and Jeannine Sheehan.
View institutional ownership trends
.

How do I buy shares of InfuSystem?

Shares of INFU stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

What other stocks do shareholders of InfuSystem own?

Based on aggregate information from My MarketBeat watchlists, some other companies that InfuSystem investors own include American Express (AXP), AudioCodes (AUDC), Activision Blizzard (ATVI), Atmos Energy (ATO), Amkor Technology (AMKR).

This page (NYSE:INFU) was last updated on 9/16/2024 by MarketBeat.com Staff

From Our Partners